RARE

Revealing Antibiotic Resistance Evolution

 Coordinatore Sabanci University 

 Organization address address: Orhanli Tuzla
city: ISTANBUL
postcode: 34956

contact info
Titolo: Ms.
Nome: Aslihan
Cognome: Eran
Email: send email
Telefono: +90 216 4839693
Fax: +90 216 4839118

 Nazionalità Coordinatore Turkey [TR]
 Totale costo 100˙000 €
 EC contributo 100˙000 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2011-CIG
 Funding Scheme MC-CIG
 Anno di inizio 2012
 Periodo (anno-mese-giorno) 2012-02-01   -   2016-01-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    Sabanci University

 Organization address address: Orhanli Tuzla
city: ISTANBUL
postcode: 34956

contact info
Titolo: Ms.
Nome: Aslihan
Cognome: Eran
Email: send email
Telefono: +90 216 4839693
Fax: +90 216 4839118

TR (ISTANBUL) coordinator 100˙000.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

problem    antibiotic    bacterial    antibiotics    measuring    drug    evolution    health    resistance   

 Obiettivo del progetto (Objective)

'Antimicrobial resistance is a global public health problem. Bacteria can quickly develop resistance against many of the existing antimicrobials, and consequently prolonged treatment periods lead to human suffering, loss of productivity, and high health care costs. In order to tackle the antibiotic resistance problem, either new antibiotics or methods for using the current collection of antibiotics more efficiently is necessary. Here, I propose an experimental study to uncover the evolution of bacterial drug resistance which I believe will be very valuable for slowing down the spread of resistance by using the currently available antibiotics. The specific aims of this proposal are: (1) Measuring the rates of evolution under single drug and drug combination treatments; (2) Examining pleiotropic effects of (non-drug) stressful conditions on evolution of drug resistance; (3) Measuring the epistatic interactions between mutations that confer antibiotic resistance. We will perform these studies by using high-throughput measurements and a custom made fully automated fluidics system, “the morbidostat”, which can unequivocally follow bacterial evolution in antibiotic environments. Being able to understand the evolution of antibiotic resistance both at the population and enzymatic level, and identifying the pleitropic effects that cause antibiotic resistance will be very helpful for planning interventions to combat antibiotic resistance.'

Altri progetti dello stesso programma (FP7-PEOPLE)

CRITICS (2011)

Towards targeting chemokine receptors CCR7 and CCRL1 to control the crossroads of tumor-host interactions

Read More  

WEAKLY CONFINED RMT (2011)

Spontaneous Symmetry Breaking in Random Matrices: a model for the Anderson Transition from String Theory

Read More  

ECOLASSA (2010)

Molecular and serological techniques to study Lassa virus ecology

Read More